1. Insights
  2. News
  3. Press Releases

Akin Advises Pharmakon in its Up to $125 Million Credit Facility for Precigen

September 5, 2025

Reading Time : 1 min
Jump to
View People Mentioned in This NewsView Related Services, Sectors, and Regions

Contact:

Alexandra Field

Director of Communications

Send Email
+1 212.407.3167

Jacinta O'Shea-Ramdeholl

Senior Manager, International Communications

Send Email
+1 212.407.3080

(New York and Washington, D.C.) – Akin advised Pharmakon Advisors, LP and its affiliated funds in providing Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, with up to $125 million committed, non-dilutive financing across two tranches. 

The Akin team was led by tax partner Geoffrey Secol and included fellow tax partners Stuart Leblang and David Synder; corporate associates Jake Gawlak and Yossi Abadi; and tax associate John Kwack. Additional support was provided by international trade partner Nnedinma Ifudu Nweke; and health care & life sciences partner Nate Brown, senior counsel Jo-Ellyn Klein, counsel Caroline Kessler and associate Olive Lee.  

For additional information, please click here.  

Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East. 

# # # 

Share This Insight

Related Services, Sectors, and Regions

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.